Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Highlighting KEYTRUDA & expanding cancer pipeline
Nearly one in five women worldwide are now living with obesity
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
Subscribe To Our Newsletter & Stay Updated
